Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Acid, N-acetylneuraminic
2. Acid, Sialic
3. N Acetylneuraminic Acid
4. N-acetylneuraminic Acid
5. Sialic Acid
1. 131-48-6
2. N-acetyl-beta-neuraminic Acid
3. N-acetylneuramic Acid
4. N-acetyl-d-neuraminic Acid
5. Lactaminic Acid
6. Nana
7. Sialic Acid
8. Beta-neu5ac
9. Beta-sialic Acid
10. 19342-33-7
11. N-acetylsialic Acid
12. 5-acetamido-3,5-dideoxy-d-glycero-d-galactononulosonic Acid
13. Tip79w5hpn
14. (2s,4s,5r,6r)-5-acetamido-2,4-dihydroxy-6-[(1r,2r)-1,2,3-trihydroxypropyl]oxane-2-carboxylic Acid
15. Chembl165084
16. Chebi:45744
17. (2s,4s,5r,6r)-5-acetamido-2,4-dihydroxy-6-((1r,2r)-1,2,3-trihydroxypropyl)tetrahydro-2h-pyran-2-carboxylic Acid
18. Acide Aceneuramique
19. 489-46-3
20. O-sialic Acid
21. Mfcd00006620
22. 5-acetamido-3,5-dideoxy-d-glycero-beta-d-galacto-non-2-ulopyranosonic Acid
23. Slb
24. 5-n-acetylneuraminic Acid
25. N-acetylneuraminicacid
26. Unii-tip79w5hpn
27. Lactaminate
28. Sialomucin
29. Aceneuramic-acid
30. N-acetylsialate
31. B-sialic Acid
32. Nsc111756
33. N-acetylneuramate
34. 4mmp
35. 4mnp
36. N-acetyl-neuraminate
37. Neu-5ac
38. 5-n-acetylneuraminate
39. N-acetyl-b-neuraminate
40. N-acetyl-d-neuraminate
41. 126934-33-6
42. N-acetyl-b-d-neuraminate
43. Neuraminic Acid, N-acetyl
44. 5-n-acetyl-d-neuraminate
45. N-acetyl-delta-neuraminate
46. Schembl22412
47. 5-n-acetyl-delta-neuraminate
48. Mls002207179
49. Nan
50. N-acetyl-b-d-neuraminic Acid
51. Neuraminic Acid, N-acetyl- Starburst 4th Generation
52. 5-acetamido-3,5-dideoxy-d-glycero-d-galacto-nonulopyranosonic Acid
53. N-acetyl-delta-neuraminic Acid
54. N-acetyl-beta-delta-neuraminate
55. N-acetyl-beta-d-neuraminic Acid
56. 5-n-acetyl-b-d-neuraminic Acid
57. Dtxsid80864309
58. 5-n-acetyl-delta-neuraminic Acid
59. (-)-n-acetyl-beta-neuraminic Acid
60. N-acetyl-beta-delta-neuraminic Acid
61. Zinc3793840
62. N-(-)-acetylneuraminic Acid
63. Bdbm50063302
64. S4792
65. 5-n-acetyl-beta-delta-neuraminic Acid
66. Akos016004587
67. Am83978
68. Ccg-267571
69. Db04265
70. N-acetyl-.beta.-neuraminic Acid
71. Ac-24185
72. As-13907
73. Smr000857174
74. .beta.-neuraminic Acid, N-acetyl-
75. N-acetyl-.beta.-d-neuraminic Acid
76. N-acetylneuraminic Acid, Analytical Standard
77. N-acetylneuraminic Acid, Synthetic, >=95%
78. A1105
79. (-)-n-acetyl-.beta.-neuraminic Acid
80. A-1600
81. C19910
82. En300-174088
83. N-acetyl-.beta.-neuraminic Acid, (-)-
84. 131a486
85. (-)-n-acetylneuraminic Acid, Synthetic, Crystalline
86. N-acetylneuraminic Acid, Cell Culture Tested, >=95%
87. Q27120624
88. N-acetylneuraminic Acid, From Escherichia Coli, >=98%
89. Z1741971506
90. 5-acetamido-3,5-dideoxy-d-glycero-d-galacto-nonulosonate
91. 028d6d24-32a0-45ed-857e-4138653435fb
92. 5-(acetylamino)-3,5-dideoxy-d-glycero-d-galacto-2-nonulosonate
93. 5-acetamido-3,5-dideoxy-delta-glycero-delta-galacto-nonulosonate
94. 5-acetamido-3,5-dideoxy-delta-glycero-delta-galacto-nonulosonic Acid
95. B-5-acetamido-3,5-dideoxy-d-glycero-d-galacto-nonulopyranosonate
96. Wurcs=2.0/1,1,0/[aad21122h-2b_2-6_5*ncc/3=o]/1/
97. 5-(acetylamino)-3,5-dideoxy-d-glycero-b-d-galacto-2-nonulopyranosonate
98. 5-(acetylamino)-3,5-dideoxy-d-glycero-b-d-galacto-2-nonulopyranosonic Acid
99. 5-(acetylamino)-3,5-dideoxy-delta-glycero-delta-galacto-2-nonulosonate
100. 5-(acetylamino)-3,5-dideoxy-delta-glycero-delta-galacto-2-nonulosonic Acid
101. B-5-acetamido-3,5-dideoxy-d-glycero-d-galacto-nonulopyranosonic Acid
102. Beta-5-acetamido-3,5-dideoxy-delta-glycero-delta-galacto-nonulopyranosonate
103. 5-(acetylamino)-3,5-dideoxy-d-glycero-beta-d-galacto-non-2-ulopyranosonic Acid
104. 5-(acetylamino)-3,5-dideoxy-delta-glycero-beta-delta-galacto-2-nonulopyranosonate
105. 5-(acetylamino)-3,5-dideoxy-delta-glycero-beta-delta-galacto-2-nonulopyranosonic Acid
106. Beta-5-acetamido-3,5-dideoxy-delta-glycero-delta-galacto-nonulopyranosonic Acid
107. D-glycero-.beta.-d-galacto-2-nonulopyranosonic Acid, 5-(acetylamino)-3,5-dideoxy-
108. D-glycero-d-galacto-nonulopyranosonic Acid, 5-acetamido-3,5-dideoxy-, .beta.-
109. (2s,4s,5r,6r)-5-acetamido-2,4-dihydroxy-6-[(1r,2r)-1,2,3-trihydroxypropyl]tetrahydropyran-2-carboxylic Acid
110. N-acetylneuraminic Acid; Sialic Acid; O-sialic Acid; 5-n-acetyl-beta-d-neuraminic Acid; Beta-sialic Acid
| Molecular Weight | 309.27 g/mol |
|---|---|
| Molecular Formula | C11H19NO9 |
| XLogP3 | -3.5 |
| Hydrogen Bond Donor Count | 7 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 5 |
| Exact Mass | g/mol |
| Monoisotopic Mass | g/mol |
| Topological Polar Surface Area | 177 |
| Heavy Atom Count | 21 |
| Formal Charge | 0 |
| Complexity | 403 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 6 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Treatment of distal myopathy, Nonaka type (hereditary inclusion-body myopathy)
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A N-Acetyl-D-neuraminate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of N-Acetyl-D-neuraminate, including repackagers and relabelers. The FDA regulates N-Acetyl-D-neuraminate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. N-Acetyl-D-neuraminate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of N-Acetyl-D-neuraminate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A N-Acetyl-D-neuraminate supplier is an individual or a company that provides N-Acetyl-D-neuraminate active pharmaceutical ingredient (API) or N-Acetyl-D-neuraminate finished formulations upon request. The N-Acetyl-D-neuraminate suppliers may include N-Acetyl-D-neuraminate API manufacturers, exporters, distributors and traders.
click here to find a list of N-Acetyl-D-neuraminate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
N-Acetyl-D-neuraminate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of N-Acetyl-D-neuraminate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right N-Acetyl-D-neuraminate GMP manufacturer or N-Acetyl-D-neuraminate GMP API supplier for your needs.
A N-Acetyl-D-neuraminate CoA (Certificate of Analysis) is a formal document that attests to N-Acetyl-D-neuraminate's compliance with N-Acetyl-D-neuraminate specifications and serves as a tool for batch-level quality control.
N-Acetyl-D-neuraminate CoA mostly includes findings from lab analyses of a specific batch. For each N-Acetyl-D-neuraminate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
N-Acetyl-D-neuraminate may be tested according to a variety of international standards, such as European Pharmacopoeia (N-Acetyl-D-neuraminate EP), N-Acetyl-D-neuraminate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (N-Acetyl-D-neuraminate USP).
LOOKING FOR A SUPPLIER?
